
D. Margaret M. Seaman
Examiner (ID: 14125, Phone: (571)272-0694 , Office: P/1625 )
| Most Active Art Unit | 1625 |
| Art Unit(s) | 1625, 1612, 1621, 1203 |
| Total Applications | 3093 |
| Issued Applications | 2274 |
| Pending Applications | 282 |
| Abandoned Applications | 572 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 13687247
[patent_doc_number] => 20170354578
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-12-14
[patent_title] => Preparation of Zinc Citrate and of Zinc Citrate-Containing Oral Care Compositions
[patent_app_type] => utility
[patent_app_number] => 15/521058
[patent_app_country] => US
[patent_app_date] => 2014-10-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4884
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 86
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15521058
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/521058 | Preparation of zinc citrate and of zinc citrate-containing oral care compositions | Oct 23, 2014 | Issued |
Array
(
[id] => 9793411
[patent_doc_number] => 20150005355
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-01-01
[patent_title] => 'COMBINATION THERAPY WITH PARP INHIBITORS'
[patent_app_type] => utility
[patent_app_number] => 14/485307
[patent_app_country] => US
[patent_app_date] => 2014-09-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 25
[patent_figures_cnt] => 25
[patent_no_of_words] => 13661
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14485307
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/485307 | COMBINATION THERAPY WITH PARP INHIBITORS | Sep 11, 2014 | Abandoned |
Array
(
[id] => 9793410
[patent_doc_number] => 20150005354
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-01-01
[patent_title] => 'Combination Therapy With Parp Inhibitors'
[patent_app_type] => utility
[patent_app_number] => 14/484971
[patent_app_country] => US
[patent_app_date] => 2014-09-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 15
[patent_no_of_words] => 10456
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14484971
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/484971 | Combination Therapy With Parp Inhibitors | Sep 11, 2014 | Abandoned |
Array
(
[id] => 9895145
[patent_doc_number] => 20150050343
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-02-19
[patent_title] => 'METHODS OF WOUND CARE AND TREATMENT'
[patent_app_type] => utility
[patent_app_number] => 14/336558
[patent_app_country] => US
[patent_app_date] => 2014-07-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 91
[patent_figures_cnt] => 91
[patent_no_of_words] => 64557
[patent_no_of_claims] => 65
[patent_no_of_ind_claims] => 25
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14336558
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/336558 | METHODS OF WOUND CARE AND TREATMENT | Jul 20, 2014 | Abandoned |
Array
(
[id] => 9812066
[patent_doc_number] => 20150024010
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-01-22
[patent_title] => 'METHODS OF THERAPEUTIC TREATMENT OF EYES'
[patent_app_type] => utility
[patent_app_number] => 14/336307
[patent_app_country] => US
[patent_app_date] => 2014-07-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 92
[patent_figures_cnt] => 92
[patent_no_of_words] => 65557
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14336307
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/336307 | METHODS OF THERAPEUTIC TREATMENT OF EYES | Jul 20, 2014 | Abandoned |
Array
(
[id] => 9909049
[patent_doc_number] => 20150064251
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-03-05
[patent_title] => 'Tamper Resistant Dosage Form Composition And Process Of Making The Same'
[patent_app_type] => utility
[patent_app_number] => 14/323412
[patent_app_country] => US
[patent_app_date] => 2014-07-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 8498
[patent_no_of_claims] => 43
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14323412
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/323412 | Tamper Resistant Dosage Form Composition And Process Of Making The Same | Jul 2, 2014 | Abandoned |
Array
(
[id] => 10255114
[patent_doc_number] => 20150140111
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-05-21
[patent_title] => 'PREPARATIONS OF EFFERVESCENT FORMULATIONS COMPRISING SECOND AND THIRD GENERATION CEPHALOSPORIN AND USES THEREOF'
[patent_app_type] => utility
[patent_app_number] => 14/309273
[patent_app_country] => US
[patent_app_date] => 2014-06-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11791
[patent_no_of_claims] => 69
[patent_no_of_ind_claims] => 28
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14309273
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/309273 | PREPARATIONS OF EFFERVESCENT FORMULATIONS COMPRISING SECOND AND THIRD GENERATION CEPHALOSPORIN AND USES THEREOF | Jun 18, 2014 | Abandoned |
Array
(
[id] => 9719798
[patent_doc_number] => 20140255497
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-09-11
[patent_title] => 'Organic Compounds'
[patent_app_type] => utility
[patent_app_number] => 14/285808
[patent_app_country] => US
[patent_app_date] => 2014-05-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6815
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14285808
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/285808 | Organic Compounds | May 22, 2014 | Abandoned |
Array
(
[id] => 10620565
[patent_doc_number] => 09339489
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2016-05-17
[patent_title] => 'Rapid disperse dosage form containing levetiracetam'
[patent_app_type] => utility
[patent_app_number] => 14/277901
[patent_app_country] => US
[patent_app_date] => 2014-05-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 7
[patent_no_of_words] => 17484
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 67
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14277901
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/277901 | Rapid disperse dosage form containing levetiracetam | May 14, 2014 | Issued |
Array
(
[id] => 10443150
[patent_doc_number] => 20150328162
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-11-19
[patent_title] => 'PHARMACEUTICAL PREPARATIONS'
[patent_app_type] => utility
[patent_app_number] => 14/278772
[patent_app_country] => US
[patent_app_date] => 2014-05-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 2476
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14278772
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/278772 | PHARMACEUTICAL PREPARATIONS | May 14, 2014 | Abandoned |
Array
(
[id] => 15604211
[patent_doc_number] => 10583146
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-03-10
[patent_title] => Pharmaceutical compositions for glucocorticoid replacement therapy
[patent_app_type] => utility
[patent_app_number] => 14/255332
[patent_app_country] => US
[patent_app_date] => 2014-04-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 20
[patent_figures_cnt] => 20
[patent_no_of_words] => 14516
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 162
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14255332
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/255332 | Pharmaceutical compositions for glucocorticoid replacement therapy | Apr 16, 2014 | Issued |
Array
(
[id] => 12465981
[patent_doc_number] => 09987233
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-06-05
[patent_title] => Injectable sustained release composition and method of using the same for treating inflammation in joints and pain associated therewith
[patent_app_type] => utility
[patent_app_number] => 14/222082
[patent_app_country] => US
[patent_app_date] => 2014-03-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 16
[patent_no_of_words] => 14006
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 157
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14222082
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/222082 | Injectable sustained release composition and method of using the same for treating inflammation in joints and pain associated therewith | Mar 20, 2014 | Issued |
Array
(
[id] => 10919277
[patent_doc_number] => 20140322296
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-10-30
[patent_title] => 'PIPERAQUINE MICROCAPSULES AND COMPOSITIONS CONTAINING THEM'
[patent_app_type] => utility
[patent_app_number] => 14/222102
[patent_app_country] => US
[patent_app_date] => 2014-03-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 9780
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14222102
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/222102 | PIPERAQUINE MICROCAPSULES AND COMPOSITIONS CONTAINING THEM | Mar 20, 2014 | Abandoned |
Array
(
[id] => 15449287
[patent_doc_number] => 10548874
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-02-04
[patent_title] => Nanoparticulate phosphate adsorbent on the basis of maghemite or maghemite/magnetite, production and uses thereof
[patent_app_type] => utility
[patent_app_number] => 14/200292
[patent_app_country] => US
[patent_app_date] => 2014-03-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 18168
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 138
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14200292
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/200292 | Nanoparticulate phosphate adsorbent on the basis of maghemite or maghemite/magnetite, production and uses thereof | Mar 6, 2014 | Issued |
Array
(
[id] => 9568736
[patent_doc_number] => 20140186449
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-07-03
[patent_title] => 'CONTROLLED RELEASE PREPARATION'
[patent_app_type] => utility
[patent_app_number] => 14/199334
[patent_app_country] => US
[patent_app_date] => 2014-03-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 71917
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14199334
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/199334 | CONTROLLED RELEASE PREPARATION | Mar 5, 2014 | Abandoned |
Array
(
[id] => 9805297
[patent_doc_number] => 20150017241
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-01-15
[patent_title] => 'ORAL FORMULATIONS OF DEFERASIROX'
[patent_app_type] => utility
[patent_app_number] => 14/198872
[patent_app_country] => US
[patent_app_date] => 2014-03-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 7698
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14198872
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/198872 | Oral formulations of deferasirox | Mar 5, 2014 | Issued |
Array
(
[id] => 9568735
[patent_doc_number] => 20140186448
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-07-03
[patent_title] => 'CONTROLLED RELEASE PREPARATION'
[patent_app_type] => utility
[patent_app_number] => 14/199308
[patent_app_country] => US
[patent_app_date] => 2014-03-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 71917
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14199308
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/199308 | CONTROLLED RELEASE PREPARATION | Mar 5, 2014 | Abandoned |
Array
(
[id] => 10654525
[patent_doc_number] => 20160000669
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-01-07
[patent_title] => 'RESORCINOL COMPOUNDS FOR DERMATOLOGICAL USE'
[patent_app_type] => utility
[patent_app_number] => 14/771062
[patent_app_country] => US
[patent_app_date] => 2014-03-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19555
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14771062
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/771062 | Resorcinol compounds for dermatological use | Mar 5, 2014 | Issued |
Array
(
[id] => 10662327
[patent_doc_number] => 20160008471
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-01-14
[patent_title] => 'TRANSDERMAL FORMULATIONS'
[patent_app_type] => utility
[patent_app_number] => 14/771192
[patent_app_country] => US
[patent_app_date] => 2014-02-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 32106
[patent_no_of_claims] => 38
[patent_no_of_ind_claims] => 16
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14771192
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/771192 | TRANSDERMAL FORMULATIONS | Feb 26, 2014 | Abandoned |
Array
(
[id] => 9756299
[patent_doc_number] => 20140287000
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-09-25
[patent_title] => 'TUMOR PROLIFERATION INHIBITOR CONTAINING ULTRASOUND-SENSITIVE SUBSTANCE AND METHOD FOR INHIBITING TUMOR PROLIFERATION BY USING TUMOR PROLIFERATION INHIBITOR AND LOW-INTENSITY PULSED ULTRASOUND WAVES'
[patent_app_type] => utility
[patent_app_number] => 14/186859
[patent_app_country] => US
[patent_app_date] => 2014-02-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 3146
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14186859
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/186859 | Tumor proliferation inhibitor containing ultrasound-sensitive substance and method for inhibiting tumor proliferation by using tumor proliferation inhibitor and low-intensity pulsed ultrasound waves | Feb 20, 2014 | Issued |